GEN

Targeting Interleukin-15 Could Reawaken Dormant NK Cells in Tumors

Some immune cells in our bodies see their “killer instinct” restricted after entering solid tumors, according to new research. Now, researchers from the University of Birmingham and the University of ...
Morningstar

Forlong Biotechology to Present Clinical Data from FL115, a novel interleukin-15 (IL-15) superagonist, in Late-breaking Session at 40th SITC Annual Meeting

Forlong Biotechology to Present Clinical Data from FL115, a novel interleukin-15 (IL-15) superagonist, in Late-breaking Session at 40th SITC Annual Meeting Forlong Biotechnology, a clinical-stage ...
Nature

Interleukin-15-armoured GPC3 CAR T cells for patients with solid cancers

The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...
Morningstar

Forlong Dosed First Patient in Phase 2 Clinical Trial of FL115, a novel interleukin-15 (IL-15) superagonist, for nonmuscle invasive bladder cancer (NMIBC)

Forlong Dosed First Patient in Phase 2 Clinical Trial of FL115, a novel interleukin-15 (IL-15) superagonist, for nonmuscle invasive bladder cancer (NMIBC) Forlong Biotechnology, a clinical-stage ...